Cargando…
Mitochondria-associated endoplasmic reticulum membranes and cardiac hypertrophy: Molecular mechanisms and therapeutic targets
Cardiac hypertrophy has been shown to compensate for cardiac performance and improve ventricular wall tension as well as oxygen consumption. This compensatory response results in several heart diseases, which include ischemia disease, hypertension, heart failure, and valvular disease. Although the p...
Autores principales: | Luan, Yi, Jin, Yage, Zhang, Pengjie, Li, Hongqiang, Yang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630933/ https://www.ncbi.nlm.nih.gov/pubmed/36337896 http://dx.doi.org/10.3389/fcvm.2022.1015722 |
Ejemplares similares
-
Editorial: Recent advances in mitochondria-associated endoplasmic reticulum membranes (MAMs) in heart-related diseases
por: Yang, Yang, et al.
Publicado: (2023) -
Mitochondria-associated endoplasmic reticulum membranes (MAMs): Possible therapeutic targets in heart failure
por: Zhang, Yu, et al.
Publicado: (2023) -
Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy
por: Yang, Dan, et al.
Publicado: (2022) -
IL-6/STAT3 Signaling Promotes Cardiac Dysfunction by Upregulating FUNDC1-Dependent Mitochondria-Associated Endoplasmic Reticulum Membranes Formation in Sepsis Mice
por: Jiang, Tao, et al.
Publicado: (2022) -
Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
por: Han, Yu, et al.
Publicado: (2022)